STEMCELL Technologies has commercially launched the CellPore Transfection System, providing a groundbreaking new technology with the potential to advance cell engineering research and the...
Vertex Pharmaceuticals Incorporated announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) submission for suzetrigine, an investigational, oral,...
Pillar Biosciences, Inc., the leader in Decision Medicine™, has announced that Molecular Pathology Laboratory Network, Inc., (MPLN) is now the first national molecular reference...
GSK plc and Flagship Pioneering (Flagship), the bioplatform innovation company, announced they have entered a collaboration with the goal of discovering and developing a...
Verastem Oncology, a biopharmaceutical company committed to advancing new medicines for patients, announced that the U.S. Food and Drug Administration (FDA) has granted Orphan...
